Gemmer Asset Management LLC Moderna, Inc. Transaction History

Gemmer Asset Management LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 22, 2022	SELL	$117.13 - $176.59 $5,153 - $7,769	-44 Closed	0 $0
Q1 2022 Apr 20, 2022	BUY	$126.46 - $235.05 $126 - $235	1 Added 2.33%	44 $7,000
Q4 2021 Jan 21, 2022	BUY	$225.82 - $368.51 $3,161 - $5,159	14 Added 48.28%	43 $11,000
Q3 2021 Oct 19, 2021	SELL	$221.9 - $484.47 $3,328 - $7,267	-15 Reduced 34.09%	29 $11,000
Q1 2021 Apr 20, 2021	SELL	$109.18 - $185.98 $1,746 - $2,975	-16 Reduced 26.67%	44 $6,000
Q3 2020 Oct 21, 2020	SELL	$54.34 - $94.85 $2,173 - $3,794	-40 Reduced 40.0%	60 $4,000
Q2 2020 Jul 31, 2020	BUY	$29.67 - $80.0 $2,225 - $6,000	75 Added 300.0%	100 $6,000
Q1 2020 May 01, 2020	BUY	$17.78 - $31.58 $444 - $789	25 New	25 $0

954

241M

10.6M

18.7M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $14.4B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Gemmer Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Gemmer Asset Management LLC with notifications on news.